Ispire Malaysia says Johor plant operating above board
Health minister Dzulkefly Ahmad had said that the Cabinet would decide on the fate of Ispire Malaysia Sdn Bhd's operations in Senai, Johor. (LinkedIn pic)
PETALING JAYA : Ispire Malaysia Sdn Bhd today affirmed that its plant in Senai, Johor, which manufactures electronic cigarette devices, is fully compliant with local laws and regulations.
In a statement, the firm said it operates under stringent procedures to ensure that all manufacturing activities at its Johor facility are exclusively for export purposes.
'To date, Ispire Malaysia exclusively manufactures semi-finished hardware products destined solely for export.
'These products do not contain any nicotine or cannabis – liquid or gel – and thus are not subject to the health ministry's regulations under the Control of Smoking Products for Public Health Act 2024,' it said.
It added that the products manufactured in its Johor facility are not marketed, sold, or distributed within Malaysia and not accessible to local consumers.
All finished products are exported to regulated international markets such as the US and UK where they are approved for sale by local regulators, the company said.
The firm also said that references cited in recent reports were largely drawn from Ispire's official US website and pertained to its business-to-business sales operations in jurisdictions where cannabis and related products are legal.
'These statements do not accurately reflect the operations of Ispire Malaysia, which strictly adheres to all Malaysian laws and regulatory requirements/frameworks,' it said.
Health think tank CodeBlue previously reported that Ispire produces nicotine and cannabis-related vaping products, and that its devices are used by clients to fill cartridges with cannabis oils in global markets.
The report cited an investor presentation in Las Vegas in April, published on YouTube on May 6, which stated that Ispire produces 'mainly cannabis-related products' in its Malaysian manufacturing facility, which has up to seven production lines.
In a statement last week, the health ministry confirmed that the government had issued Ispire an interim nicotine manufacturing licence to produce e-cigarettes with nicotine in its plant in Johor, together with local council approval.
However, CodeBlue noted that the ministry's June 2 statement did not mention the plant's production of cannabis vaporisers, which reportedly began in February 2024.
Ispire Malaysia today said that any production of nicotine-based products, if initiated, would be strictly for export and subject to formal approval by all relevant government agencies at both federal and state levels.
Yesterday, health minister Dzulkefly Ahmad said that the Cabinet would decide on the fate of Ispire's operations in Malaysia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
9 minutes ago
- Malay Mail
Ringgit ticks up as ‘Big, Beautiful Bill' debate keeps traders watching
KUALA LUMPUR, June 11 — The ringgit opened higher against the US dollar on Wednesday, as the market resumed its observation on further trade negotiations between the United States (US) and China in London, an analyst said. At 8 am, the local note rose to 4.2290/2380 versus the greenback from Tuesday's close of 4.2360/2420. Bank Muamalat Malaysia Bhd chief economist Mohd Afzanizam Abdul Rashid said the US dollar index (DXY) see-sawed between 98.962 and 99.358 last night as traders and investors continued to monitor the US-China trade talks. 'US secretary of commerce Howard Lutnick described the discussion as running well, suggesting the two nations could potentially arrive at a midway (point) in their negotiations,' he told Bernama. Meanwhile, Mohd Afzanizam said the debate on US President Donald Trump's 'Big, Beautiful Bill' is still ongoing among the US Senate, as some Republicans are pushing for the phasing out of the clean-energy tax credit on the grounds of protecting investors and jobs from major disruptions. He said the US fiscal position would be in the spotlight as fiscal deficits and government debt are expected to climb. 'While market sentiments demonstrated a positive sign, it is still an early day. On that note, we expect the ringgit-dollar exchange to remain range-bound between 4.23 and 4.24 today,' he said At the opening, the ringgit traded mostly higher against a basket of major currencies. It rose against the Japanese yen to 2.9200/9264 from Tuesday's close of 2.9270/9314, and strengthened versus the British pound to 5.7121/7243 from 5.7152/7233, but marginally lower vis-a-vis the euro to 4.8367/8470 from 4.8354/8422 yesterday. The local currency traded higher against its ASEAN peers. It gained versus the Singapore dollar to 3.2885/2957 from 3.2932/2981 at Tuesday's close and improved against the Thai baht to 12.9664/13.0040 from 12.9712/9955. The ringgit was slightly higher vis-a-vis the Philippine peso at 7.57/7.59 from 7.58/7.60 yesterday and inched up against the Indonesian rupiah to 259.8/260.5 from 260.2/260.7 previously. — Bernama
Borneo Post
2 hours ago
- Borneo Post
Upcoming summit in Kuching to highlight green mobility
Hallman (seated, centre) and his committee members promote the 'Green Mobility Innovation Summit 2025', set to be held in Kuching this Sept 8 and 9.7 KUCHING (June 11): The Ministry of Education, Innovation and Talent Development Sarawak, in collaboration with the Brunei-Indonesia-Malaysia-Philippines East Asean Growth Area (BIMP-EAGA) and Sarawak Skills, will be holding the 'Green Mobility Innovation Summit 2025' at Imperial Hotel Kuching, this Sept 8 and 9. Themed 'Driving the Future: Talent, Innovation and Sustainability in Green Mobility', the event is set to propel regional sustainable transport and green economy agenda. 'This year's summit theme reflects the urgent need to develop forward-looking strategies for a greener, more sustainable transport ecosystem in Southeast Asia,' said Sarawak Skills in a statement yesterday. 'The event is set to bring together policymakers, industry leaders, educators, and innovators from across the region to share expertise, foster collaboration, and promote the development of sustainable transportation solutions. 'It serves as a key component of the BIMP-EAGA Vision 2025 initiative, which aims to enhance regional connectivity and sustainable development. 'Central to this vision is the promotion of eco-friendly practices in infrastructure development, efforts to improve climate resilience, and the implementation of smart city initiatives designed to reduce carbon emissions and support environmental sustainability,' it added. In the same statement, Sarawak Skills executive director Hallman Sabri remarked: 'The significance of gathering various experts and delegates in the field of green mobility lies in its potential to nurture talent for sustainable transportation – an objective that is not merely a local priority, but a shared regional goal under the BIMP-EAGA Vision 2025. 'Therefore, the summit serves as an essential platform for aligning strategies, building competencies, and fostering regional cooperation in the transition toward a green economy.' The Green Mobility Innovation Summit 2025 is expected to feature more than 30 distinguished speakers and moderators from all across Asean, the UK, China, and Australia. Discussions will revolve around several key themes including 'Talent Development Through Education and Training', 'Innovative Technologies', 'Governance', and 'Global Collaboration'. 'The summit is deeply aligned with Sarawak's broader commitment to environmental stewardship and sustainable development. 'As outlined in the Post Covid-19 Development Strategy (PCDS) 2030, the Sarawak government is prioritising the green economy as a strategic growth area. 'The state has already made significant strides in clean energy and sustainable mobility. 'Among these efforts is Sarawak's pioneering work in hydrogen fuel technology, including the introduction of Southeast Asia's first hydrogen-powered buses,' said Hallman in the statement. He added that the state was also expanding its electric vehicle (EV) charging infrastructure and advancing smart city development in the urban centres, including Kuching. 'Additionally, Sarawak is investing heavily in TVET (technical and vocational education and training) to equip its workforce with the skills needed for the green and digital economy. 'These state-level initiatives position Sarawak as an ideal host for the summit and underscore its leadership in driving innovation and sustainability in the region. 'The organisers invite all participants to be part of this landmark event. 'Opportunities for collaboration are available across multiple areas, including speaker engagements, delegate participation, exhibition showcases, and joint promotional initiatives,' he pointed out. Supported by Business Events Sarawak (BE Sarawak), the Tribe Legacy Sarawak Campaign, and Sarawak–More to Discover, the 'Green Mobility Innovation Summit 2025' presents a unique platform to connect with thought leaders, explore cutting-edge technologies, and contribute to shaping a more sustainable future for the region. For further information or to register, contact Linda John Tambie via 011-2992 9916 or [email protected] ; Flavian Jerry Francis via 013-835 5675 or [email protected] ; or the secretariat via [email protected] . To know more, go to
Malay Mail
2 hours ago
- Malay Mail
What to know about Ozempic: Diabetes drug used off-label for weight loss sparks warnings
KUALA LUMPUR, June 11 — As global interest in weight loss remedies grows, the off-label use of diabetes medication Ozempic for shedding pounds in non-diabetic individuals has emerged as a trend. This rising popularity, fuelled by social media and anecdotal success stories, has prompted medical professionals to caution against its unsupervised use. Here's what you need to know about Ozempic, its side effects, and why expert supervision is essential before considering it for weight loss. What is Ozempic? Ozempic is a medication primarily approved for managing type 2 diabetes. Its active ingredient, semaglutide, mimics a hormone that targets areas of the brain involved in appetite regulation. Initially designed for diabetes treatment, Ozempic has gained popularity as a weight loss aid, even among non-diabetic individuals. Can Ozempic be used for weight loss? According to Universiti Teknologi MARA consultant endocrinologist Prof Dr Rohana Abdul Ghani, Ozempic is not intended for use as a weight loss medication for non-diabetic patients. 'Ozempic is approved in Malaysia specifically for managing type 2 diabetes. However, semaglutide's weight loss benefits have led some to seek it off-label for obesity treatment,' she said. For non-diabetic patients, semaglutide should be administered at a higher dose of 2.4mg weekly under another brand name, which is unavailable in Malaysia, she added. 'The off-label use of Ozempic among non-diabetic patients has led to a shortage for those with type 2 diabetes and reduced efficacy due to the lower dose,' said Dr Rohana. She also highlighted studies suggesting that regular use of weight loss drugs might establish a 'new normal' in the body, potentially leading to weight gain. One study in the New England Journal of Medicine found that low doses of semaglutide (between 0.25mg and 0.5mg) were linked to weight gain in some patients. What are the potential side effects? As with any medication, Ozempic comes with potential side effects. Dr Rohana said common gastrointestinal side effects include nausea, vomiting, constipation, or diarrhoea, which are typically self-limiting and subside within one to two weeks. She added that rare side effects include skin reactions at the injection site and worsening eyesight, particularly in patients with high blood sugar experiencing rapid improvement. 'Ozempic should not be used by patients with a history of thyroid cancer due to the rare risk of pancreatitis,' she said. Who shouldn't take Ozempic without medical advice? Dr Rohana stressed that no one should take Ozempic without consulting a doctor. 'Medications like Ozempic for obesity should be paired with proper diet and lifestyle changes. Without these, there's a risk of complications such as significant muscle mass loss or kidney issues from severe vomiting,' she said. 'These medications should only be prescribed by clinicians who are familiar with their effects and risks,' she added.
